Found: 60
Select item for more details and to access through your institution.
Health-related quality of life in long-term survivors of unresectable locally advanced non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Postoperative Radiotherapy for Resected Pathological Stage IIIA-N2 Non-Small Cell Lung Cancer: A Retrospective Study of 221 Cases from a Single Institution.
- Published in:
- Oncologist, 2011, v. 16, n. 5, p. 641, doi. 10.1634/theoncologist.2010-0343
- By:
- Publication type:
- Article
Superiority of integrated cervicothoracic immobilization in the setup of lung cancer patients treated with supraclavicular station irradiation.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1135879
- By:
- Publication type:
- Article
Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.998238
- By:
- Publication type:
- Article
Severe radiation-induced lymphopenia during postoperative radiotherapy or chemoradiotherapy has poor prognosis in patients with stage IIB-III after radical esophagectomy: A post hoc analysis of a randomized controlled trial.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.936684
- By:
- Publication type:
- Article
Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced nonsmall-cell lung cancer: protocol for a randomized phase II trial (InTRist study).
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1341584
- By:
- Publication type:
- Article
Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1281888
- By:
- Publication type:
- Article
Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5879, doi. 10.3390/cancers14235879
- By:
- Publication type:
- Article
A Single Center Analysis of Thymic Neuroendocrine Tumors †.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4944, doi. 10.3390/cancers14194944
- By:
- Publication type:
- Article
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Radiotherapy combined with gefitinib for patients with locally advanced non-small cell lung cancer who are unfit for surgery or concurrent chemoradiotherapy: a phase II clinical trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Postoperative Adjuvant Therapy Versus Surgery Alone for Stage IIB--III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. e2151, doi. 10.1002/onco.13914
- By:
- Publication type:
- Article
Postoperative Radiotherapy in Pathological T2–3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. e701, doi. 10.1634/theoncologist.2019-0276
- By:
- Publication type:
- Article
Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
- Published in:
- Oncologist, 2016, v. 21, n. 12, p. 1530, doi. 10.1634/theoncologist.2016-0155
- By:
- Publication type:
- Article
Local Therapy Combined With First-Line EGFR Tyrosine Kinase Inhibitor Achieves Favorable Survival in Patients With EGFR-Mutant Metastatic Non-Small Cell Lung Cancer.
- Published in:
- Clinical Medicine Insights: Oncology, 2022, p. 1, doi. 10.1177/11795549221080347
- By:
- Publication type:
- Article
Clinical outcomes and prognostic factors in limited-stage small cell lung cancer; a single institution experience.
- Published in:
- Chinese Journal of Oncology, 2015, v. 37, n. 3, p. 223, doi. 10.3760/cma.j.issn.0253-3766.2015.03.015
- By:
- Publication type:
- Article
Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 23, p. 5423, doi. 10.1002/cncr.26206
- By:
- Publication type:
- Article
Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A deep learning method for producing ventilation images from 4DCT: First comparison with technegas SPECT ventilation.
- Published in:
- Medical Physics, 2020, v. 47, n. 3, p. 1249, doi. 10.1002/mp.14004
- By:
- Publication type:
- Article
Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Treatment outcomes of patients with stage III non–small cell lung cancer and interstitial lung diseases receiving intensity‐modulated radiation therapy: A single‐center experience of 85 cases.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 11, p. 1583, doi. 10.1111/1759-7714.14418
- By:
- Publication type:
- Article
Development and validation of a prediction model using molecular marker for long‐term survival in unresectable stage III non‐small cell lung cancer treated with chemoradiotherapy.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 3, p. 296, doi. 10.1111/1759-7714.14218
- By:
- Publication type:
- Article
Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score‐matched analysis.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 12, p. 1831, doi. 10.1111/1759-7714.13971
- By:
- Publication type:
- Article
Clinical outcomes and radiation pneumonitis after concurrent EGFR‐tyrosine kinase inhibitors and radiotherapy for unresectable stage III non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 6, p. 814, doi. 10.1111/1759-7714.13816
- By:
- Publication type:
- Article
Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: Results from a Chinese two‐center study.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 6, p. 1431, doi. 10.1111/1759-7714.13088
- By:
- Publication type:
- Article
Impact of thoracic radiation therapy after chemotherapy on survival in extensive‐stage small cell lung cancer: A propensity score‐matched analysis.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 799, doi. 10.1111/1759-7714.13001
- By:
- Publication type:
- Article
Radical thoracic radiotherapy may provide favorable outcomes for stage IV non-small cell lung cancer.
- Published in:
- Thoracic Cancer, 2016, v. 7, n. 2, p. 182, doi. 10.1111/1759-7714.12305
- By:
- Publication type:
- Article
Role of radiotherapy in treating patients with primary malignant mediastinal non-seminomatous germ cell tumor: A 21-year experience at a single institution.
- Published in:
- Thoracic Cancer, 2015, v. 6, n. 4, p. 399, doi. 10.1111/1759-7714.12190
- By:
- Publication type:
- Article
Efficacy of intensity-modulated radiotherapy for resected thoracic esophageal squamous cell carcinoma.
- Published in:
- Thoracic Cancer, 2015, v. 6, n. 5, p. 597, doi. 10.1111/1759-7714.12228
- By:
- Publication type:
- Article
Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy.
- Published in:
- Thoracic Cancer, 2015, v. 6, n. 3, p. 346, doi. 10.1111/1759-7714.12186
- By:
- Publication type:
- Article
Prognosis of esophageal squamous cell carcinoma patients with preoperative radiotherapy: Comparison of different cancer staging systems.
- Published in:
- Thoracic Cancer, 2014, v. 5, n. 3, p. 204, doi. 10.1111/1759-7714.12079
- By:
- Publication type:
- Article
Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221108693
- By:
- Publication type:
- Article
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211061948
- By:
- Publication type:
- Article
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211061948
- By:
- Publication type:
- Article
Postoperative Intensity-Modulated Radiotherapy Improved Survival in Lymph Node-Positive or Stage III Thoracic Esophageal Squamous Cell Carcinoma.
- Published in:
- Oncology Research & Treatment, 2015, v. 38, n. 3, p. 97, doi. 10.1159/000375391
- By:
- Publication type:
- Article
Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.918787
- By:
- Publication type:
- Article
Adenoid Cystic Carcinoma of Lobar Bronchial Origin: 20-Year Experience at a Single Institution.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 7, p. 4408, doi. 10.1245/s10434-022-11590-5
- By:
- Publication type:
- Article
Comparison of Two Major Staging Systems in Predicting Survival and Recommendation of Postoperative Radiotherapy Based on the 11th Japanese Classification for Esophageal Carcinoma After Curative Resection: A Propensity Score-Matched Analysis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7076, doi. 10.1245/s10434-021-10046-6
- By:
- Publication type:
- Article
Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 9, p. 2890, doi. 10.1245/s10434-019-07393-w
- By:
- Publication type:
- Article
CHST15 promotes the proliferation of TE-1 cells via multiple pathways in esophageal cancer.
- Published in:
- Oncology Reports, 2020, v. 43, n. 1, p. 75, doi. 10.3892/or.2019.7395
- By:
- Publication type:
- Article
MicroRNA-Related Polymorphisms in PI3K/Akt/mTOR Pathway Genes Are Predictive of Limited-Disease Small Cell Lung Cancer Treatment Outcomes.
- Published in:
- BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/6501385
- By:
- Publication type:
- Article
Definitive Simultaneous Integrated Boost Versus Conventional-Fractionated Intensity Modulated Radiotherapy for Patients With Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.618776
- By:
- Publication type:
- Article
Sparing Organs at Risk with Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Locally Advanced Non-Small Cell Lung Cancer: An Automatic Treatment Planning Study.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 9643, doi. 10.2147/CMAR.S273197
- By:
- Publication type:
- Article
Residual lymph node status is an independent prognostic factor in esophageal squamous cell Carcinoma with pathologic T0 after preoperative radiotherapy.
- Published in:
- Radiation Oncology, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13014-015-0450-4
- By:
- Publication type:
- Article
Postoperative radiotherapy for completely resected Masaoka stage III thymoma: a retrospective study of 65 cases from a single institution.
- Published in:
- Radiation Oncology, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1748-717X-8-199
- By:
- Publication type:
- Article
Postoperative radiotherapy for completely resected Masaoka stage III thymoma: a retrospective study of 65 cases from a single institution.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer.
- Published in:
- Radiation Oncology, 2012, v. 7, n. 1, p. 119, doi. 10.1186/1748-717X-7-119
- By:
- Publication type:
- Article